Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-10-05, Stock:LLY, The news for the past five days is as follows:
2021-09-28: NEWS1: FDA Expands Lilly's ERBITUX® (cetuximab) Label with Combination of BRAFTOVI® (encorafenib) for the Treatment of BRAF V600E Mutation-Positive Metastatic Colorectal Cancer (CRC) after Prior Therapy.NEWS2: 3 Growth Stocks That Can Help You Retire Early.NEWS3: Hedge Funds Have Never Been This Bullish On Eli Lilly and Company (LLY).NEWS4: UPDATE 1-Lilly to cut price of Lispro insulin injection by 40% from Jan. 1.NEWS5: Eli Lilly to reduce list price of Insulin Lispro injection by an additional 40% from Jan. 1, restoring it to 2008 levels.NEWS6: Lilly again reduces list price of Insulin Lispro Injection as latest change to affordability options.NEWS7: 3 COVID Stocks Ready to Take On the Delta Variant.
2021-09-29: NEWS1: Why Eli Lilly Shares Are Moving Higher Today.NEWS2: Lilly Stock Upgrades to Buy from Neutral After Shares Decline.NEWS3: Lilly and Susan G. Komen® Partner to Address Disparities in Breast Cancer Outcomes Experienced By Black Women.NEWS4: Lilly's (LLY) Erbitux Gets FDA Nod for Expanded Use in CRC.NEWS5: 5 Top Stock Gainers for Wednesday: Dollar Tree, Boeing, Netflix.NEWS6: 10 Biggest Price Target Changes For Wednesday.NEWS7: Lucid, Eli Lilly, Boeing Rise Premarket; Micron Falls.
2021-09-30: NEWS1: Top Stock Reports for Eli Lilly, Costco & Applied Materials.NEWS2: Eli Lilly Shares Positive Tirzepatide Data At EASD Annual Meeting.NEWS3: OLUMIANT® Significantly Improved Hair Regrowth to At Least 80% Scalp Coverage as Early as 24 Weeks Across First Completed Phase 3 Studies for Alopecia Areata.NEWS4: Lilly's tirzepatide led to greater improvements in liver fat content compared to insulin degludec in adults with type 2 diabetes in SURPASS-3 MRI sub-study.NEWS5: Lilly's tirzepatide led to greater time in range compared to insulin degludec in adults with type 2 diabetes in SURPASS-3 CGM sub-study.
2021-10-01: NEWS1: Eli Lilly's Mirikizumab Maintains Symptomatic Remission for Two Years In Ulcerative Colitis Patients.NEWS2: Pharma Stock Roundup: MRK to Buy XLRN, ABBV Gets FDA Nod for Migraine Drug & More.NEWS3: At Week 104, 75% of Patients with Ulcerative Colitis Taking Mirikizumab Maintained Symptomatic Remission in Phase 2 Study.NEWS4: The Zacks Analyst Blog Highlights: Eli Lilly, Costco, Applied Materials, Illumina and Norfolk Southern Corp.
2021-10-04: NEWS1: Exclusive: Eli Lilly’s recalled emergency diabetes drug came from plant cited by FDA.NEWS2: Ready for the Challenge? Boehringer Ingelheim and Eli Lilly and Company Launch First Ever Online Game on Cardio-Renal-Metabolic Conditions for Healthcare Professionals.NEWS3: Cipla to sell Lilly's Trulicity, Humalog diabetes treatments in India.

Answer: Rise